To examine tumor cell growth inhibition in response to HK2 knockdown, we investigated the consequences of expressing an HK2-targeted doxycycline (DOX)-inducible shRNA in our panel of HK1−HK2+ and HK1+HK2+ liver cancer cell lines. The gene discussed is HK2; the disease is liver cancer.